Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

heelstick Press Releases

  + XML/RSS  



By MediPurpose™
New White Paper Examines Neonatal Heelstick’s Adherence to Safe in Common’ Rules for Sharps Safety

By MediPurpose™
Examines babyLance Safety Heelstick’s Activation, Ease of Use, Incision Quality and Safety

By MediPurpose™
Analyzes End-Users Expectations, Clinical Studies, and FDA Guidance Documents and 510(k) with Sharps Safety Indication Application

By MediPurpose™
Reflects U.S. FDA 510(k) Clearance for Marketing Neonatal Heelstick Device with a Sharps Prevention...

By MediPurpose™
Examines Additional Considerations for Sharps Prevention Features and Submissions for a Modified Medical Device with Existing 510(k)...

By MediPurpose™
Clinical Use Studies Also Show 94-Percent Score for Ease-of-Use, Ergonomics and Performance Tests

By MediPurpose™
Authorizes Medical Product Company to Continue Distributing babyLance™ Safety Heelsticks and SurgiLance™ Safety Lancets in Canada

By MediPurpose Pte.
Recertification Validates MediPurpose’s Medical Product Quality Management System (QMS)

By MediPurpose™
Results From Simulated and Clinical Use Survey at Citrus Valley Medical Center

By MediPurpose™
babyLance Heelstick Reinvention Process Prioritized Harmony Between End-User Ergonomic Requirements and Design Team Innovation

By MediPurpose™
Study Completes Two-Year Redesign Phase, Enabling Launch of New Neonatal Medical Device

By MediPurpose™
Renewal Validates Company's Medical Device Development Quality Management System and Enables CE Marking for EU Medical Product Sales

By MediPurpose™
New babyLance Heelstick Design Exceeds Benchmarks for Safety, Ergonomics

By MediPurpose®
Joins Kentec Medical and KOL Bio-Medical Instruments as Exclusive Regional Distributors in Western and Eastern United States

By MediPurpose®
Results Indicate New babyLance(r) Delivers an Ideal Incision

By MediPurpose®
Follows Recent White Paper That Described a Heelstick Trigger Activation Survey to Support Company's Redesign of babyLance Infant Heel Incision Device

By MediPurpose®
The white paper's key findings indicate a majority preference for a new design's pull trigger, validating the company's decision to move forward with a redesign of its heelstick device.

By Derek Rudnak | MediPurpose®
Seasoned Medical Device Engineer Brings More Than 30 Years of Expertise to Medical Product Company

By Derek Rudnak | MediPurpose®
The Medical Device's Trademark is Also Registered in the United States, China, South Korea, Singapore and Switzerland

By Derek Rudnak | MediPurpose
Medical Product Company Also Bids Farewell to President/CSO Randy Prather

All Press Releases

By MediPurpose™
New White Paper Examines Neonatal Heelstick’s Adherence to Safe in Common’ Rules for Sharps Safety

By MediPurpose™
Examines babyLance Safety Heelstick’s Activation, Ease of Use, Incision Quality and Safety

By MediPurpose™
Analyzes End-Users Expectations, Clinical Studies, and FDA Guidance Documents and 510(k) with Sharps Safety Indication Application

By MediPurpose™
Reflects U.S. FDA 510(k) Clearance for Marketing Neonatal Heelstick Device with a Sharps Prevention...

By MediPurpose™
Examines Additional Considerations for Sharps Prevention Features and Submissions for a Modified Medical Device with Existing 510(k)...

By MediPurpose™
Clinical Use Studies Also Show 94-Percent Score for Ease-of-Use, Ergonomics and Performance Tests

By MediPurpose™
Authorizes Medical Product Company to Continue Distributing babyLance™ Safety Heelsticks and SurgiLance™ Safety Lancets in Canada

By MediPurpose Pte.
Recertification Validates MediPurpose’s Medical Product Quality Management System (QMS)

By MediPurpose™
Results From Simulated and Clinical Use Survey at Citrus Valley Medical Center

By MediPurpose™
babyLance Heelstick Reinvention Process Prioritized Harmony Between End-User Ergonomic Requirements and Design Team Innovation

By MediPurpose™
Study Completes Two-Year Redesign Phase, Enabling Launch of New Neonatal Medical Device

By MediPurpose™
Renewal Validates Company's Medical Device Development Quality Management System and Enables CE Marking for EU Medical Product Sales

By MediPurpose™
New babyLance Heelstick Design Exceeds Benchmarks for Safety, Ergonomics

By MediPurpose®
Joins Kentec Medical and KOL Bio-Medical Instruments as Exclusive Regional Distributors in Western and Eastern United States

By MediPurpose®
Results Indicate New babyLance(r) Delivers an Ideal Incision

By MediPurpose®
Follows Recent White Paper That Described a Heelstick Trigger Activation Survey to Support Company's Redesign of babyLance Infant Heel Incision Device

By MediPurpose®
The white paper's key findings indicate a majority preference for a new design's pull trigger, validating the company's decision to move forward with a redesign of its heelstick device.

By Derek Rudnak | MediPurpose®
Seasoned Medical Device Engineer Brings More Than 30 Years of Expertise to Medical Product Company

By Derek Rudnak | MediPurpose®
The Medical Device's Trademark is Also Registered in the United States, China, South Korea, Singapore and Switzerland

By Derek Rudnak | MediPurpose
Medical Product Company Also Bids Farewell to President/CSO Randy Prather

By Derek Rudnak | MediPurpose
Attendees Can Earn Entries by Evaluating the babyLance Heel Incision Device at MediPurpose Booth 436

By Derek Rudnak | MediPurpose®
Equivalent of U.S. FDA Registration, CA Registration Enables Distribution of babyLance in Italy

By Derek Rudnak | MediPurpose®
New Distribution Partnership with Haemoclub International SLR Already Reporting Considerable Interest in Italy for MediPurpose’s Fingersticks and Infant Heelsticks

By Derek Rudnak | MediPurpose®
The Statement of Grant of Protection issued by the Japan Patent Office protects both the word "babyLance" and the neonatal heel stick's unique blue and green logo.

By Derek Rudnak | MediPurpose®
MediPurpose(r), a master distributor and manufacturer of medical products, today announced Medikus as the exclusive Austrian distributor for its babyLance(r) infant heel incision device.

By Derek Rudnak | MediPurpose®
MediPurpose®, a master distributor and manufacturer of medical products, today announced that its trademark for the babyLance® infant heel incision device has been registered with the United States Patent and Trademark Office.

By Derek Rudnak | MediPurpose®
‘Ease of Use’ a Factor in NICU Manager’s Decision

By Derek Rudnak | MediPurpose
Follows Recent Naming of Midwest Distributor, MED Alliance Group

By Derek Rudnak | MediPurpose
Launched last July, babyLance™ heel incision devices are a safe, easy and effective solution for neonatal caregivers to collect blood samples from infants.

By Derek Rudnak | MediPurpose
Novation, a leading healthcare supply contracting company, is now offering babyLance™ infant heel incision devices to the 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC) and nearly 15,000 members of Provista, LLC.

By Derek Rudnak | MediPurpose
A complement to the company's vastly popular line of SurgiLance safety lancets, babyLance is a safe, easy and effective solution for newborn heel incisions.



Page:
  • 1

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share